Head and Neck Cancer Trial, Recruiting NCT05854823 Sponsor: Fifth Affiliated Hospital, Sun Yat-Sen University Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT05854823
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People diagnosed with a specific type of head and neck cancer (squamous cell carcinoma) affecting the mouth, throat, voice box, or nearby areas, at a certain stage of advancement, who have already received pre-surgery treatment and then had surgery to remove the cancer — all within the past 6 weeks.
  • People whose surgical tissue samples showed either no remaining cancer cells, or very few remaining cancer cells (10% or less) after pre-surgery treatment.
  • People whose surgery removed all cancer with clear edges — meaning no cancer cells were found at the borders of the removed tissue.
  • People whose cancer had not spread beyond the lymph nodes into surrounding tissue.
  • People aged 18 to 70 years old.
  • People who are generally able to carry out daily activities, ranging from fully active to capable of limited self-care (confirm with trial site for exact fitness level required).
  • People expected to live for more than 6 months.
  • People whose blood counts, liver, kidney, and clotting function all meet certain minimum health levels as measured by blood tests (confirm with trial site for exact values).
  • Women who are able to become pregnant and agree to use contraception during treatment and for 3 months afterwards.
  • People who have agreed to take part voluntarily and have signed a consent form.

Who may not be able to join:

  • Women who are pregnant or currently breastfeeding.
  • People who have had another type of cancer in the past 5 years, except for certain fully treated skin cancers, cervical pre-cancers, or thyroid papilloma.
  • People who did not complete their planned pre-surgery treatment or their surgery.
  • People whose cancer has come back or spread to other parts of the body before post-surgery radiotherapy has begun.
  • People who have medical reasons that prevent them from safely receiving radiotherapy, chemotherapy, immunotherapy, or targeted therapy.
  • People with serious or uncontrolled heart conditions or symptoms.
  • People with serious active infections.
  • People with a history of immune system disorders, HIV, other conditions that weaken the immune system, or who have had an organ or bone marrow transplant.
  • People with active tuberculosis (TB), a TB infection in the past year, or a past TB infection that was never properly treated.
  • People with active hepatitis B or hepatitis C infection, based on specific blood test results (confirm with trial site for exact thresholds).
  • People with a known history of misusing alcohol, recreational drugs, or substances that affect the mind.
  • People considered unsuitable by the trial investigators for any other reason.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 07562526191

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fifth Affiliated Hospital, Sun Yat-Sen University
Registry
ClinicalTrials.gov
Start date
10 April 2023
Est. completion
9 April 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Disease Free Survival (DFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov